Step 1 Of 3

Female sexual dysfunction (FSD) is a serious health problem for women that has become ubiquitous nowadays for various reasons. The most common symptoms of FSD are decreased libido, decreased physical arousal, decreased vaginal lubrication, loss of vaginal tone or conversely excessive shrinkage or tightening of the vaginal canal, loss of vaginal sensation, decreased ability to orgasm, decreased strength of orgasm, and painful intercourse. These symptoms can cause women to suffer from a decreased qualify of life, and can cause a lot of stress for women in general
Must be an active patient with lab work and a prescription from a medical provider
This appointment is designed for clients who want to utilize specific medical services at Rising Health without undergoing a full new patient evaluation. It is intended for patients who are already under the care of another provider for their primary health needs but require services like:
- IV Ozone Therapy (requires a G6PD order)
- IV Vitamin C (over 25g, also requires a G6PD order)
- Hyperbaric Oxygen Therapy (HBOT) (provider must understand the purpose of the treatment)
- NAD IV Therapy and other IV services
- Stem Cell injections
- Joint injections
- Trigger point injections
Important Notes:
- We will not be prescribing medications, except for necessary orders to provide the services listed.
- Only a G6PD lab test will be drawn if required for certain therapies. If patients request additional lab work, they will need to schedule a **New Patient Wellness Appointment.
- Major medical history and vitals will be collected during the appointment to ensure the patient's safety during treatment.
$499 lab program
Most comprehensive individualized profile available (preferred for all baselinetesting)? Combination of Onconomics and Onconomics Extracts Panels? Includes chemosensitivity testing of both chemotherapeutic agents ANDnatural substances? Answers the question: “Which are the most eective chemotherapeuticagents and natural substances?”? Detects the presence and number of CTCs (does not contain phenotype orstemness markers as does Oncotrace and Oncotrail RGCC)? Analyzes validated tumor-related Gene expressions used for customization oftreatment protocols? Includes Resistance Factors to further refine timing and rotation of treatmentprotocols? Includes Chemosensitivity (Pharmacodynamic) testing to determine theeectiveness of >50 Chemotherapeutic agents + 60 targeted drugs + >50natural substances + 5 additional substances upon request at no additionalcost? For hematologic (blood) & solid tumors? Sample Type: Blood